147 related articles for article (PubMed ID: 34817126)
21. Topical sulfasalazine for unresponsive oral lichen planus.
Jeong SH; Na HS; Park SH; Ahn YW; Chung J
Quintessence Int; 2016 Apr; 47(4):319-27. PubMed ID: 26504904
[TBL] [Abstract][Full Text] [Related]
22. Interventions for treating oral lichen planus: corticosteroid therapies.
Lodi G; Manfredi M; Mercadante V; Murphy R; Carrozzo M
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001168. PubMed ID: 32108333
[TBL] [Abstract][Full Text] [Related]
23. Serum vitamin D level in healthy individuals versus patients with symptomatic and asymptomatic oral lichen planus.
Lama H M; Hussein F; Sadek H; Abdelghany W
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 68(2):19-25. PubMed ID: 35869723
[TBL] [Abstract][Full Text] [Related]
24. Salivary cytokine profile in patients with oral lichen planus.
Zhu ZD; Ren XM; Zhou MM; Chen QM; Hua H; Li CL
J Dent Sci; 2022 Jan; 17(1):100-105. PubMed ID: 35028026
[TBL] [Abstract][Full Text] [Related]
25. Salivary expression of lncRNA DQ786243 and IL-17 in oral lichen planus: case-control study.
Abdeldayem E; Rashed L; Ali S
BMC Oral Health; 2022 Jun; 22(1):240. PubMed ID: 35717182
[TBL] [Abstract][Full Text] [Related]
26. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases.
Lisa Cheng YS; Jordan L; Gorugantula LM; Schneiderman E; Chen HS; Rees T
J Periodontol; 2014 Jul; 85(7):956-65. PubMed ID: 24147842
[TBL] [Abstract][Full Text] [Related]
27. Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus.
Corrocher G; Di Lorenzo G; Martinelli N; Mansueto P; Biasi D; Nocini PF; Lombardo G; Fior A; Corrocher R; Bambara LM; Gelio S; Pacor ML
J Clin Periodontol; 2008 Mar; 35(3):244-9. PubMed ID: 18269664
[TBL] [Abstract][Full Text] [Related]
28. Cytokines, cortisol, and nitric oxide as salivary biomarkers in oral lichen planus: a systematic review.
Humberto JSM; Pavanin JV; Rocha MJAD; Motta ACF
Braz Oral Res; 2018 Aug; 32():e82. PubMed ID: 30110084
[TBL] [Abstract][Full Text] [Related]
29. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.
Rhodus NL; Cheng B; Ondrey F
Mediators Inflamm; 2007; 2007():19854. PubMed ID: 17497029
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population.
Liu W; Dan H; Wang Z; Jiang L; Zhou Y; Zhao M; Chen Q; Zeng X
Inflammation; 2009 Jun; 32(3):176-81. PubMed ID: 19370405
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of the efficacy of Nigella sativa (75% v/v) cream and clobetasol propionate (0.05% w/w) gel in oral lichen planus-a double-blinded randomized control trial.
Kumar S L; Naik Z; Panwar A; M S; Keluskar V; Kumar RS
Oral Maxillofac Surg; 2024 Mar; 28(1):225-234. PubMed ID: 36547822
[TBL] [Abstract][Full Text] [Related]
32. Single session of laser photobiomodulation for symptom management of oral lichen planus: a retrospective study.
Roccon A; Cavallin F; Zanette G; Bacci C
Lasers Med Sci; 2023 Jan; 38(1):43. PubMed ID: 36656450
[TBL] [Abstract][Full Text] [Related]
33. IL-25 promotes Th2-type reactions and correlates with disease severity in the pathogenesis of oral lichen planus.
Wang H; Jiang Y; Wang H; Luo Z; Wang Y; Guan X
Arch Oral Biol; 2019 Feb; 98():115-121. PubMed ID: 30472360
[TBL] [Abstract][Full Text] [Related]
34. Alteration of Streptococcus salivarius in Buccal Mucosa of Oral Lichen Planus and Controlled Clinical Trial in OLP Treatment.
Li Y; Shao F; Zheng S; Tan Z; He Y
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1340-1348. PubMed ID: 32506228
[TBL] [Abstract][Full Text] [Related]
35. Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus.
Arduino PG; Campolongo MG; Sciannameo V; Conrotto D; Gambino A; Cabras M; Ricceri F; Carossa S; Broccoletti R; Carbone M
Oral Dis; 2018 Jul; 24(5):772-777. PubMed ID: 29297958
[TBL] [Abstract][Full Text] [Related]
36. Serum and salivary interleukin-4 levels in patients with oral lichen planus: A systematic review and meta-analysis.
Mozaffari HR; Zavattaro E; Saeedi M; Lopez-Jornet P; Sadeghi M; Safaei M; Imani MM; Nourbakhsh R; Moradpoor H; Golshah A; Sharifi R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Aug; 128(2):123-131. PubMed ID: 31097393
[TBL] [Abstract][Full Text] [Related]
37. A Comparison of the Characteristics of Cytokine Storm between Lichen Planus and Oral Squamous Cell Carcinoma.
Kalbassi S; Radfar L; Azimi M; Shadanpoor S; Ghorbani Ranjbary A
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3843-3849. PubMed ID: 36444597
[TBL] [Abstract][Full Text] [Related]
38. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus.
Yamamoto T; Osaki T; Yoneda K; Ueta E
J Oral Pathol Med; 1994 Aug; 23(7):309-15. PubMed ID: 7965886
[TBL] [Abstract][Full Text] [Related]
39. Salivary and serum levels of tumor necrosis factor-alpha in oral lichen planus: a systematic review and meta-analysis study.
Mozaffari HR; Ramezani M; Mahmoudiahmadabadi M; Omidpanah N; Sadeghi M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):e183-e189. PubMed ID: 28823317
[TBL] [Abstract][Full Text] [Related]
40. Inflammation-related cytokines in oral lichen planus: an overview.
Lu R; Zhang J; Sun W; Du G; Zhou G
J Oral Pathol Med; 2015 Jan; 44(1):1-14. PubMed ID: 24329772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
